OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Release Date
2023
(4)
2021
(2)
2025
(1)
2024
(1)
2022
(1)
2020
(1)
2019
(1)
2016
(1)
2015
(1)
2014
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Isatuximab monotherapy in patients with refractory T-acute lymphoblastic leukemia or T-lymphoblastic lymphoma: Phase 2 study.
Not available
S-EPMC8894690
|
biostudies-literature
Cite
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
Not available
S-EPMC4271347
|
biostudies-literature
Cite
Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.
Not available
S-EPMC4879693
|
biostudies-literature
Cite
Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice.
Not available
S-EPMC4966538
|
biostudies-literature
Cite
Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin Lymphoma.
Not available
S-EPMC12560943
|
biostudies-literature
Cite
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.
Not available
S-EPMC10587711
|
biostudies-literature
Cite
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.
Not available
S-EPMC12865819
|
biostudies-literature
Cite
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial.
Not available
S-EPMC7596685
|
biostudies-literature
Cite
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.
Not available
S-EPMC5090978
|
biostudies-literature
Cite
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
Not available
S-EPMC8488725
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets